COVID-19 Updates

Visit UC San Diego's Coronavirus portal for the latest information for the campus community.

ACTRI Welcomes Eugene Sato

August 9, 2018

Eugene Sato, PhD, has joined ACTRI as the project manager for the Tricorder Device Development Project, which kicked off in June. In this new role, Sato is responsible for working with the top competitors from the Qualcomm Tricorder XPRIZE to test their next-generation Star Trek®-inspired medical devices. He co-planned the project’s first meeting and will manage the clinical trials for the devices this fall at the ACTRI clinic and in the field.

Sato received a bachelor’s degree in biomedical engineering from Johns Hopkins and a PhD in bioengineering from UC San Diego, joining the Qualcomm Tricorder XPRIZE as Technical Director shortly after he defended his dissertation. “I came on board with the competition in 2016 to help with the testing of Tricorder prototypes, inclduing set-up and troubleshooting the devices with the teams, and to help them find volunteers for testing their devices,” Sato said. “I had the best seat in the house. I saw all the teams, their creativity and their systems.” ACTRI had been the testing site for the competition, which concluded in 2017.

He said he is fascinated by the five finalist teams and their creations. The teams have varying personalities, which are reflected in their technologies, and are at different stages with their projects, which are in different niches. He emphasized how the new ACTRI testing facility for the development and commercialization of the devices is important to the future of health. “One of the things that hasn’t opened up yet is a reliable, actionable health app,” Sato said. “Patient and consumer-friendly FDA-approved medical devices combined with diagnostic algorithms could improve health outcomes whilst saving money, time, and resources. We could help with the burden for both patients and doctors.”

About UC San Diego Altman Clinical and Translational Research Institute:

UC San Diego Altman Clinical and Translational Research Institute (ACTRI) is part of a national Clinical and Translational Science Award consortium, led by the National Institutes of Health National Center for Advancing Translational Science. Established in 2010, ACTRI provides infrastructure and support for basic, translational and clinical research throughout the San Diego region to bring discoveries from the laboratory to the bedside, and facilitates training and education of the next generation of researchers. ACTRI carries out its activities in collaboration with institutional and corporate partners and currently has more than 1,425 members.